Ryuichi Moriya, Ph.D.
Dr. Moriya joined Astellas in 2009 and has engaged in Antibody Drug Discovery at Tsukuba Research Center and Antibody Drug Conjugate research at Agensys, a subsidiary in the United States. In 2018, he was appointed Head of the Targeted Medicine Laboratory and has experience as a Primary Focus Modality Lead. He has been in his present position since October 2023.
Akihiro Ohashi, Ph.D.
Division Head, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center
Affiliate Associate Professor, Graduate School of Frontier Science, The University of Tokyo
Affiliate Associate Professor, Research Institute for Biomedical Sciences, Tokyo University of Science